Ya, to make profit in the stock market, apart from foresight and luck etc, it also requires guts.
halleluyah ( Date: 18-Dec-2012 20:16) Posted:
No, i was strongly discouraged by my brokers. Only intra day trading is ok. I gt no guts n no peace after the advise. Anyway, may the Lord bless u n others wth abundant of profit
counter ( Date: 18-Dec-2012 19:11) Posted:
Anyway, I will be surprised if the shortists stop trying. However, I will be even more surprised if they can gather the same kind of momentum. If they succeed, then good for them. If they don’t, the price will go up further. I don't intend to sell my shares after BCD. Let nature take its course.
Btw, you said you were waiting to long Olam. Did you manage to get some?
No, i was strongly discouraged by my brokers. Only intra day trading is ok. I gt no guts n no peace after the advise. Anyway, may the Lord bless u n others wth abundant of profit
counter ( Date: 18-Dec-2012 19:11) Posted:
Anyway, I will be surprised if the shortists stop trying. However, I will be even more surprised if they can gather the same kind of momentum. If they succeed, then good for them. If they don’t, the price will go up further. I don't intend to sell my shares after BCD. Let nature take its course.
Btw, you said you were waiting to long Olam. Did you manage to get some?
counter ( Date: 18-Dec-2012 18:25) Posted:
I thought borrowing of scripts would be allowed only after BCD and not XD
Anyway, I will be surprised if the shortists stop trying. However, I will be even more surprised if they can gather the same kind of momentum. If they succeed, then good for them. If they don’t, the price will go up further. I don't intend to sell my shares after BCD. Let nature take its course.
Btw, you said you were waiting to long Olam. Did you manage to get some?
counter ( Date: 18-Dec-2012 18:25) Posted:
I thought borrowing of scripts would be allowed only after BCD and not XD.
halleluyah ( Date: 18-Dec-2012 17:59) Posted:
After the ex-rights, then will b shorting again.....show time as predicted. Poor olam !
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap.
Olam is up 5.4% at $1.47 in strong volume amid a series of large trades, suggesting institutional interest. Olam’s management is currently on an investor roadshow in the U.S., according to the company.
An analyst says this may be driving interest in the shares, especially ahead of the rights issue. The last day of Olam’s cum rights trading is Dec. 27. The stock’s Dec. 4 peak at $1.71 likely offers a near-term cap
Exercise rights is a no. But some brokers allow you to trade the rights. It depends on the broker, suggest you check with your remisier. If you are using Phillip, you wont get to trade the rights even. You need to liquidate your position before XR.
Page 3, footer point 7 - http://www.phillipcfd.com/download/PhillipCFDInfoSheet.pdf
tiancai007 ( Date: 18-Dec-2012 17:26) Posted:
By the way, using CFD cannot exercise rights and bonds right? Because physically one dont really own the shares. Correct me if I'm wrong. Tks.
Post Reply
801-820 of 934